Tirzepatide Lyophilized High Purity 99% Peptide Powder TR 10mg 15mg 20mg 30mg ib vial rau ntshav qab zib / ntshav qab zib
Product Detail
| Lub npe | Tirzepatide Txhaj Tshuaj |
| Purity | 99% |
| Qhov tshwm sim | Dawb Lyophilized Hmoov |
| Kev tswj hwm | Kev txhaj tshuaj subcutaneous |
| Loj | 10 mg, 15 mg, 20 mg, 30 mg |
| Dej | 3.0% |
| Cov txiaj ntsig | Kho ntshav qab zib, txhim kho ntshav qab zib tswj |
Kev piav qhia
Tirzepatide yog ib qho tshiab ntawm cov piam thaj-dependent insulinotropic polypeptide / glucagon-zoo li peptide 1 (GLP-1) receptor agonist tau pom zoo hauv Tebchaws Meskas raws li kev noj haus thiab kev tawm dag zog los txhim kho glycemic tswj rau cov neeg laus uas muaj ntshav qab zib hom 2 thiab hauv kev tshawb xyuas rau kev siv hauv kev noj qab haus huv, kev mob plawv thiab lwm yam kev mob plawv. thiab non-cirrhotic non-alcoholic steatohepatitis. Theem 3 SURPASS 1-5 qhov kev sim tshuaj ntsuam xyuas tau tsim los ntsuas kev ua tau zoo thiab kev nyab xeeb ntawm ib lub lim tiam subcutaneously txhaj tshuaj tirzepatide (5, 10 thiab 15 mg), raws li kev kho mob monotherapy lossis kev sib xyaw ua ke, thoob plaws qhov dav ntawm cov neeg mob ntshav qab zib hom 2. Kev siv tirzepatide hauv kev tshawb fawb soj ntsuam tau cuam tshuam nrog kev txo qis ntawm glycated hemoglobin (-1.87 txog -2.59%, -20 txog -28 mmol / mol) thiab lub cev hnyav (-6.2 txog -12.9 kg), nrog rau kev txo qis hauv cov kev cuam tshuam feem ntau cuam tshuam nrog kev nce siab ntawm cov hlab plawv, xws li ntshav siab. triglycerides. Tirzepatide tau txais txiaj ntsig zoo, nrog kev pheej hmoo tsawg ntawm hypoglycemia thaum siv yam tsis muaj cov tshuaj insulin lossis insulin secretagogues thiab pom qhov kev nyab xeeb feem ntau zoo sib xws rau GLP-1 receptor agonist chav kawm. Yog li, cov pov thawj los ntawm cov kev sim tshuaj no qhia tias tirzepatide muaj lub sijhawm tshiab rau kev txo qis glycated hemoglobin thiab lub cev hnyav rau cov neeg laus uas muaj ntshav qab zib hom 2.
